Shenzhen Bioeasy Biotechnology Co Ltd
SZSE:300942
Shenzhen Bioeasy Biotechnology Co Ltd
SZSE:300942
Price:
9.8
CNY
-0.1%
Market Cap:
¥4B
Cash Flow Statement
Cash Flow Statement
Shenzhen Bioeasy Biotechnology Co Ltd
Shenzhen Bioeasy Biotechnology Co Ltd
Currency: CNY
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
23
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(35)
|
(23)
|
(21)
|
(15)
|
(29)
|
(48)
|
(52)
|
(57)
|
(74)
|
(54)
|
(49)
|
(49)
|
(21)
|
8
|
(9)
|
8
|
17
|
(7)
|
10
|
2
|
(0)
|
(3)
|
|
| Change in Working Capital |
(147)
|
(112)
|
(111)
|
(120)
|
(109)
|
(121)
|
(145)
|
(207)
|
(246)
|
(264)
|
(263)
|
(234)
|
(208)
|
(196)
|
(149)
|
(119)
|
(107)
|
(97)
|
(106)
|
(99)
|
(107)
|
(115)
|
|
| Cash from Operating Activities |
64
N/A
|
88
+38%
|
64
-27%
|
183
+186%
|
254
+39%
|
226
-11%
|
255
+13%
|
106
-58%
|
85
-20%
|
86
+1%
|
153
+77%
|
150
-2%
|
64
-57%
|
62
-3%
|
(37)
N/A
|
26
N/A
|
49
+89%
|
37
-25%
|
34
-8%
|
23
-32%
|
19
-18%
|
26
+35%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(46)
|
(53)
|
(83)
|
(87)
|
(86)
|
(84)
|
(80)
|
(87)
|
(100)
|
(148)
|
(177)
|
(175)
|
(198)
|
(145)
|
(129)
|
(148)
|
(133)
|
(147)
|
(174)
|
(154)
|
(125)
|
(99)
|
|
| Other Items |
12
|
(302)
|
9
|
172
|
(305)
|
(124)
|
(347)
|
(133)
|
(49)
|
87
|
(13)
|
(7)
|
84
|
168
|
62
|
22
|
(106)
|
(324)
|
(173)
|
3
|
54
|
222
|
|
| Cash from Investing Activities |
(34)
N/A
|
(355)
-953%
|
(74)
+79%
|
85
N/A
|
(391)
N/A
|
(208)
+47%
|
(427)
-105%
|
(220)
+48%
|
(149)
+32%
|
(61)
+59%
|
(190)
-211%
|
(182)
+4%
|
(115)
+37%
|
23
N/A
|
(66)
N/A
|
(126)
-90%
|
(238)
-89%
|
(471)
-98%
|
(348)
+26%
|
(151)
+57%
|
(72)
+53%
|
123
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Debt |
22
|
22
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
63
|
61
|
61
|
87
|
388
|
367
|
416
|
366
|
21
|
99
|
52
|
22
|
43
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
(18)
|
(18)
|
(18)
|
0
|
(100)
|
(100)
|
(101)
|
(101)
|
(12)
|
(12)
|
(13)
|
(14)
|
(5)
|
(6)
|
(5)
|
(6)
|
(13)
|
(14)
|
|
| Other |
164
|
(47)
|
(46)
|
136
|
176
|
176
|
159
|
0
|
(28)
|
(34)
|
(15)
|
(18)
|
(15)
|
(11)
|
(21)
|
(19)
|
(16)
|
(16)
|
(6)
|
(5)
|
0
|
2
|
|
| Cash from Financing Activities |
186
N/A
|
(25)
N/A
|
(46)
-88%
|
114
N/A
|
136
+19%
|
136
0%
|
141
+3%
|
0
N/A
|
(107)
N/A
|
(71)
+34%
|
(54)
+24%
|
(58)
-8%
|
61
N/A
|
365
+501%
|
333
-9%
|
383
+15%
|
345
-10%
|
(1)
N/A
|
87
N/A
|
42
-52%
|
9
-77%
|
31
+233%
|
|
| Change in Cash | |||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
2
|
(2)
|
(10)
|
(10)
|
(13)
|
(11)
|
(5)
|
(5)
|
3
|
9
|
(1)
|
(2)
|
1
|
(8)
|
5
|
5
|
(1)
|
(1)
|
2
|
5
|
5
|
6
|
|
| Net Change in Cash |
218
N/A
|
(294)
N/A
|
(67)
+77%
|
372
N/A
|
(14)
N/A
|
143
N/A
|
(35)
N/A
|
(160)
-358%
|
(169)
-5%
|
(37)
+78%
|
(92)
-146%
|
(92)
0%
|
11
N/A
|
443
+3 826%
|
235
-47%
|
289
+23%
|
155
-46%
|
(436)
N/A
|
(225)
+48%
|
(81)
+64%
|
(38)
+53%
|
186
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
18
N/A
|
35
+94%
|
(19)
N/A
|
96
N/A
|
168
+75%
|
142
-16%
|
176
+24%
|
19
-89%
|
(15)
N/A
|
(62)
-304%
|
(24)
+61%
|
(25)
-3%
|
(134)
-437%
|
(83)
+38%
|
(166)
-101%
|
(121)
+27%
|
(83)
+32%
|
(110)
-32%
|
(140)
-27%
|
(131)
+6%
|
(106)
+19%
|
(73)
+31%
|
|
Switch to:
Switch to:
See Also
Discover More
